Over the past 12 months, 7 insiders at Elevance Health, Inc. filed 8 open-market SEC Form 4 transactions on ELV: 3 purchases worth $1.6M and 5 sales worth $1.7M. Insiders have been net sellers over this period. The most recent filing was on Jul 17, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 17, 26 | Ramiro G PeruDirector | BUY | 1.0K | $366.05 | $366K |
| Jun 12, 26 | Ronald W PenczekCAO & Controller | SELL | 369 | $403.16 | $149K |
| Jun 11, 26 | Robert L Dixon Jr | SELL | 151 | $401.77 | $61K |
| May 19, 26 | Ronald W PenczekCAO & Controller | SELL | 1.5K | $403.13 | $617K |
| Mar 12, 26 | Amy W SchulmanDirector | SELL | 26 | $287.50 | $7K |
| Mar 6, 26 | Charles Morgan Kendrick JrEVP & President, Commercial | SELL | 3.2K | $284.92 | $911K |
| Mar 5, 26 | Steven H CollisDirector | BUY | 3.0K | $289.84 | $870K |
| Aug 19, 25 | Susan D. DevoreDirector | BUY | 1.2K | $312.15 | $375K |
| Jul 18, 25 | Gail BoudreauxPresident and CEO | BUY | 5.1K | $287.96 | $1.5M |
| Apr 24, 25 | Mark KayeEVP & CFO | SELL | 4.6K | $424.82 | $1.9M |
| Mar 10, 25 | Ronald W PenczekCAO & Controller | SELL | 443 | $415.13 | $184K |
| Mar 5, 25 | Charles Morgan Kendrick JrEVP & President, Commercial | SELL | 3.5K | $396.30 | $1.4M |
| Oct 18, 24 | Charles Morgan Kendrick JrEVP & President, Commercial | SELL | 7.4K | $432.14 | $3.2M |
| Aug 5, 24 | Ramiro G PeruDirector | SELL | 753 | $531.52 | $400K |
| Jul 22, 24 | Gail BoudreauxPresident and CEO | SELL | 20.8K | $503.67 | $10.4M |
| Jul 19, 24 | Robert L Dixon JrDirector | SELL | 305 | $506.76 | $155K |
| Apr 24, 24 | Felicia F NorwoodEVP & President,Gov Health Ben | SELL | 3.4K | $532.68 | $1.8M |
| Apr 23, 24 | Felicia F NorwoodEVP & President,Gov Health Ben | SELL | 14.0K | $534.74 | $7.5M |
| Mar 8, 24 | Charles Morgan Kendrick JrEVP & President, Commercial | SELL | 2.4K | $500.46 | $1.2M |
| Mar 6, 24 | Ronald W PenczekCAO & Controller | SELL | 916 | $504.58 | $462K |
| Mar 4, 24 | Peter D HaytaianEVP & Pres Carelon & CarelonRx | SELL | 15.0K | $500.18 | $7.5M |
| Feb 7, 24 | Ramiro G PeruDirector | SELL | 753 | $500.00 | $377K |
| Dec 14, 23 | Blair Williams TodtEVP, CLO & CAO | SELL | 5.5K | $484.02 | $2.7M |
| Nov 30, 23 | Ronald W PenczekCAO & Controller | SELL | 1.1K | $475.17 | $501K |
| Oct 24, 23 | Ronald W PenczekCAO & Controller | SELL | 64 | $454.35 | $29K |
| Jul 21, 23 | Robert L Dixon JrDirector | SELL | 310 | $476.71 | $148K |
| Mar 24, 23 | Gloria M McCarthyEVP & Chief Administrative Off | SELL | 5.6K | $446.06 | $2.5M |
| Mar 9, 23 | Charles Morgan Kendrick JrEVP & President, Commercial | SELL | 2.3K | $462.22 | $1.1M |
Over the past 12 months, insiders at Elevance Health, Inc. filed 3 open-market purchases worth $1.6M and 5 sales worth $1.7M on ELV, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 17, 26.
The largest recent open-market ELV insider purchase in our data was $1.5M by Gail Boudreaux, President and CEO, filed on Jul 18, 25.
7 different insiders at Elevance Health, Inc. filed open-market SEC Form 4 transactions on ELV over the last 12 months.
InsiderTape plots every ELV insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Elevance Health, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →